Simcere Pharma (02096) spent approximately 8.0969 million Hong Kong dollars on September 19 to repurchase 1.311 million shares.
Sinopharm Pharmaceutical (02096) announced on September 19, 2024 that it will spend approximately HK$80.969 million to repurchase...
SIMCERE PHARMA (02096) announced on September 19, 2024 that it would spend approximately HK$8.0969 million to repurchase 1.31 million shares at a repurchase price of HK$6.1-6.21 per share.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
